Journal of Nanomaterials

Journal of Nanomaterials / 2009 / Article
Special Issue

Nanocomposites for Engineering Applications

View this Special Issue

Research Article | Open Access

Volume 2009 |Article ID 168041 |

Lin Li, Yi Li, Jiashen Li, Lei Yao, Arthur F. T. Mak, Frank Ko, Ling Qin, "Antibacterial Properties of Nanosilver PLLA Fibrous Membranes", Journal of Nanomaterials, vol. 2009, Article ID 168041, 5 pages, 2009.

Antibacterial Properties of Nanosilver PLLA Fibrous Membranes

Academic Editor: Alan K. T. Lau
Received15 Oct 2008
Revised13 Mar 2009
Accepted24 Apr 2009
Published27 May 2009


Nanosilver has been studied as a valuable material for it strong antibacterial effects. In this study, we investigated the antibacterial properties of nano silver Poly-L-Lactic acid (Ag/PLLA) composite fibrous membranes. Ag/PLLA fibrous membranes were prepared with silver nanoparticles having weight ratio of silver nanoparticles to PLLA at 5% (w/w). In vitro antibacterial tests were performed using Escherichia coli (E. coli) and Staphylococcus aureus (Staph.) to determine the antibacterial capability of the Ag/PLLA fibrous membranes. As the results suggested, Ag/PLLA fibrous membranes showed strong antibacterial properties. Thus, Ag/PLLA fibrous membrane can be used as an antibacterial scaffold for tissue engineering.

1. Introduction

Tissue engineering scaffolds which are supposed to be used for medical applications have applied various polymers such as degradable Poly-L-Lactide (PLLA) and Polyglycolic acid (PGA), or natural biomaterials like chitin, silk, protein, and collagen [113]. These biomaterials offer a promising new approach to help to restore and reconstruct defected tissues. An optimal scaffold for medical applications requires the following merits: suitable for cell adhesion and proliferation; highly porous for transport of nutrients and metabolic waste; biodegradable and bioresorbable. PLLA is a biocompatible, biodegradable, and immunologically inert synthetic polymer. Thus, PLLA was chosen in this study for designing a composition of tissue engineering scaffold.

In addition, the risk of infection requires tissue engineering scaffolds to have antibacterial properties [14]. For example, during the treatment of wound, infection is a common risk that need to be prevented for good healing of wound. Due to their strong antibacterial properties and low toxicity, silver and its compounds have been studied for many years not only for their low toxicity, but also for their antibacterial activity [1427]. Yeo et al. found that fibers having silver showed excellent antibacterial property [28]. Electrospinning technique was employed to produce PLLA fibers to provide a matrix with wide interface for combining antibacterial materials.

Meanwhile, the nanotechnology has provided a most promising field for the new attempts of biomedical materials [14]. Such as silver nanoparticles provide larger interface to the environment than that of microscale silver particles. Li et al. (2005) reported that nanosilver had strong antibacterial efficacy with very small amount against bacteria [17]. So, nanosized silver is a good material to reduce the quantity without decreasing antibacterial activity of silver. Thus, in this study, we used the silver nanoparticles to combine with PLLA by using electrospinning technique to fabricate biodegradable tissue engineering scaffolds with antibacterial property. E. coli and Staphylococcues which often infect wound skin and other tissues were applied for antibacterial tests to investigate the antibacterial activity of Ag/PLLA fibrous membranes [28].

2. Materials and Methods

2.1. Materials

Poly-L-Lactide (PLLA) with molecular weight of 1?000?000 was purchased from Purac, Netherlands. Silver nanoparticles (0–100?nm) with 99.9% purity and 35?nm average particle size (Figure 1) were purchased from the Shenzhen Junye Nano Material Co. Ltd.

2.2. Electrospinning of PLLA and Ag/PLLA Membranes

Electrospinning method is according to our previous study [29]. PLLA was dissolved at the weight ratio of 1% in an organic solvent mixed with the composition of chloroform and N,N-dimethlformamide (DMF) (, w/w). Silver nanoparticles were then added to the solution and stirred evenly to prepare 5% Ag/PLLA solution for electrospinning. PLLA and Ag/PLLA solutions were taken in a syringe with blunt needle, and fed by syringe plunger at a feeding rate of 0.3?mL/min. A grounded metal rotating drum wrapped with aluminum foil was located at a fixed distance of 10?cm away from the nozzle of the needle for collecting fibers. A high electric field was applied to the droplet which was coming out from the nozzle. This leads to the droplet deformation of continuous fibers. PLLA and Ag/PLLA fibrous membranes were produced under high voltage of 13?kV.

2.3. Antibacterial Test

Antibacterial test method was referred to AATCC147-2004 in this study. Escherichia coli (E. coli, ATCC25922) and Staphylococcus aureus (Staph., ATCC25923) were used for this test as the common micro-organisms involved in hospital-acquired infections [17]. The test repeated three times for every specimen.

2.3.1. Procedure

The strains were cultured overnight in 10?mL nutrient broth to achieve the turbidity of 108 colony forming units (CFU)/mL. Sterilized nutrient agar was dispensed by pouring ?mL into each standard (?mm) flat bottom petri dish to obtain firmly solid agar before inoculating. Using a 4?mm inoculating loop, loaded one loopful of the 10 times diluted inoculums and transfer to the surface of the sterile agar by making five streaks coving the central area of a petri dish. Gently press the specimen of Ag/PLLA membrane to contact intimately with the agar surface. Then incubated at C for 24 hours. PLLA membrane was used as a negative control. All specimens were prepared with the diameter of 5?mm for antibacterial test.

2.3.2. Evaluation

Examine the incubated plates for interruption of growth along the streaks of inoculum beneath the specimen and for a clear zone of inhibition beyond its edge. The average width of a zone of inhibition along a streak on either side of the test specimen was calculated using the following equation: where width of clear zone of inhibition in mm; total diameter of test specimen and clear zone in mm; diameter of the test specimen in mm.

2.4. Scanning Electron Microscopy (SEM)

PLLA and Ag/PLLA fibrous membranes with bacteria were sputter coated with gold, then observed by scanning electron microscopy (LEICA, Stereoscan 440, 20?kV).

2.5. Statistical Analysis

Values were expressed as means standard deviations. Statistical differences were determined by one-way ANOVA. P values of less than .05 were considered to be statistically significant.

3. Results

3.1. Antibacterial Activities of Ag/PLLA Fibrous Membranes

E. coli and Staph. were used for this test to evaluate the antibacterial capability of Ag/PLLA fibrous membranes. The bacteria were cultured overnight in 10?mL nutrient broth to achieve the turbidity of 108 colony forming units (CFU)/mL. A loop of each kind of bacteria at the concentration of 108?CFU/mL was taken to evenly streak the agar filled petri dishes. Each of the circular specimens with 5?mm diameter was gently pressed on the inoculated agar surface before incubation at C for 24 hours.

As shown in Figure 2, the upper specimens were PLLA membranes, the lower specimens were Ag/PLLA membranes. All the membranes were freshly prepared. After 24 hours incubation, obvious bacteria inhibition clear zones of Ag/PLLA membranes could be seen, the average width of the zones was ?mm. While no clear zone of inhibition was seen around PLLA membranes. Both Staph. and E. coli had the same results which indicated the strong antibacterial activity of Ag/PLLA.

After exposure in the air for 8 weeks, Ag/PLLA membranes were still observed antibacterial activity. The average width of bacterial inhibition zones of Ag/PLLA membranes was ?mm with E. coli, and ?mm with Staph. According to Table 1, the antibacterial activity was found to decrease significantly (see Figure 3).

BacteriaAverage width of bacteria inhibition clear zone (mm)

Escherichia coli0
Staphylococcus aureus0
Escherichia coli0
Staphylococcus aureus0

The mean values were shown for means ± SD. versus PLLA membranes.

These results showed that Ag/PLLA membranes had strong antibacterial capability. Although the membranes were exposure in the air for a long term, they were still antibacterial.

3.2. SEM Observation of Staph. on PLLA and Ag/PLLA Fibrous Membranes

The morphological changes of bacteria were also observed through SEM using Staph. 20?L diluted inoculum of Staph. at the concentration of 107?CFU/mL were spread on the PLLA and Ag/PLLA membranes, respectively, before being incubated at C for 2 hours. SEM observations were then performed.

As shown in Figure 4, the number of Staph. spread on PLLA membrane was obviously more than that on Ag/PLLA membrane. Besides, the surface of Staph. on PLLA membrane was smoother than that on Ag/PLLA membrane. This result indicated that there might be less destroy on the structure of bacteria which spread on PLLA membrane than that on Ag/PLLA membrane.

4. Discussion

Tissue engineering scaffolds with the effectiveness in reducing the possibility of infections will be more acceptable for medical applications [13]. For example, skin is the first protective barrier for all the tissues and organs, so a wound on skin will easily weaken the anti-infective capability of human body. Here we mainly focused on the feasibility to fabricate an antibacterial scaffolds for wound healing.

Nanosilver was observed to be toxic to bacteria cells. This finding suggested an exploration of the antibacterial tissue engineering scaffolds [12, 13, 24]. In 2004, Alt et al. reported that bone cement with 1% of nanosilver showed high antibacterial activity against most of the tested bacteria [13]. Yeo et al. found that fibers having nanosilver showed excellent antibacterial property. Besides, PLLA was already approved by FDA as a safe material for the clinical application. Thus, to combine silver nanoparticles and PLLA by using electrospinning technique [14] could be a good approach to produce tissue engineering scaffolds with high antibacterial effect. On the other hand, electrospun fibers can produce ventilate fibrous membranes with wide interface to highly perform their antibacterial activity.

In the antibacterial tests, PLLA membranes were set as control specimen. The Ag/PLLA membranes were found to inhibit the proliferation of E. coli and Staphylococcus significantly. On the basis of this finding, silver nanoparticles were approved to be released from PLLA fibers gradually. In terms of the degradability of PLLA, Ag/PLLA is an optimal matrix to contain silver nanoparticles and help to gradually release silver nanoparticles as PLLA degrade. Accordingly, Ag/PLLA fibrous membrane is a good candidate antibacterial substance for tissue engineering.

Meanwhile, although the Ag/PLLA membrane was proved to be antibacterial in this study, the antibacterial activity of the membrane was observed decreasing. After eight-week exposure in the air, the antibacterial activity of the Ag/PLLA fibrous membranes reduced. This result may be caused by the oxidization by the air or other reactions during the exposure. So, further investigation about the factors which affect the antibacterial properties of Ag/PLLA membrane need to be performed in the next process. These findings also suggest that it is possible to keep Ag/PLLA membrane with strong antibacterial activity for long time.

To investigate the mechanism of the antibacterial activity of Ag/PLLA membranes, morphological change of bacteria were primarily observed by SEM. More Staph. were seen on PLLA membrane than that on Ag/PLLA membrane. And the surface of Staph. on PLLA membranes was smoother than that on Ag/PLLA membranes. These findings imply that nanosilver may affect the structure of bacterial membrane, thereby cause the defunctionalization of bacteria. The mechanism of antibacterial activity of Ag/PLLA membranes needs further study to be verified.

On the other hand, based on the review of silver toxicity studies, it was reported that the possible side effects of nanoparticles had not been much investigated, so, detailed study needs to be carried out before the merchandised product is introduced to the market [30]. But, as a strong antibacterial substance, silver nanoparticles have been playing an irreplaceable role in anti-infections. Hence, the further study needs to be carried on for both the antibacterial function and toxicity of silver nanoparticles composed materials to find out the safe balance point for antibacterial scaffolds with no toxicity to the human body and environment.

5. Conclusions

This study describes the antibacterial capability of the Ag/PLLA fibrous membrane. On the basis of the observations and findings above, it can be concluded that PLLA is a good matrix for containing and gradually releasing antibacterial substance, while silver nanoparticles can provide strong antibacterial property to the Ag/PLLA fibrous membranes. Thus, Ag/PLLA fibrous membrane can be used as an antibacterial scaffold for wound healing. Besides, the factors which influence the antibacterial effect need further investigation to clarify the mechanism of antibacterial activity of Ag/PLLA membranes.


The authors would like to express their gratitude to the Hong Kong Research Grant Council, the Technology Innovation Commission/HKRITA, and the Hong Kong Polytechnic University for supporting this research through Projects PolyU 5281/03E, ITP-001-07-TP, and G-YE51.


  1. S. Sukigara, M. Gandhi, J. Ayutsede, M. Micklus, and F. Ko, “Regeneration of Bombyx mori silk by electrospinning—part 1: processing parameters and geometric properties,” Polymer, vol. 44, no. 19, pp. 5721–5727, 2003. View at: Publisher Site | Google Scholar
  2. Y. Chen, A. F. T. Mak, M. Wang, J. Li, and M. S. Wong, “PLLA scaffolds with biomimetic apatite coating and biomimetic apatite/collagen composite coating to enhance osteoblast-like cells attachment and activity,” Surface and Coatings Technology, vol. 201, no. 3-4, pp. 575–580, 2006. View at: Publisher Site | Google Scholar
  3. K. E. Park, H. K. Kang, S. J. Lee, B. M. Min, and W. H. Park, “Biomimetic nanofibrous scaffolds: preparation and characterization of PGA/Chitin blend nanofibers,” Biomacromolecules, vol. 7, no. 2, pp. 635–643, 2006. View at: Publisher Site | Google Scholar
  4. S. Sukigara, M. Gandhi, J. Ayutsede, M. Micklus, and F. Ko, “Regeneration of Bombyx mori silk by electrospinning—part 2: process optimization and empirical modeling using response surface methodology,” Polymer, vol. 45, no. 11, pp. 3701–3708, 2004. View at: Publisher Site | Google Scholar
  5. S. Putthanarat, R. K. Eby, W. Kataphinan et al., “Electrospun Bombyx mori gland silk,” Polymer, vol. 47, no. 15, pp. 5630–5632, 2006. View at: Publisher Site | Google Scholar
  6. H. K. Noh, S. W. Lee, J.-M. Kim et al., “Electrospinning of chitin nanofibers: degradation behavior and cellular response to normal human keratinocytes and fibroblasts,” Biomaterials, vol. 27, no. 21, pp. 3934–3944, 2006. View at: Publisher Site | Google Scholar
  7. K. Tomihata and Y. Ikada, “In vitro and in vivo degradation of films of chitin and its deacetylated derivatives,” Biomaterials, vol. 18, no. 7, pp. 567–575, 1997. View at: Publisher Site | Google Scholar
  8. W.-J. Li, C. T. Laurencin, E. J. Caterson, R. S. Tuan, and F. K. Ko, “Electrospun nanofibrous structure: a novel scaffold for tissue engineering,” Journal of Biomedical Materials Research, vol. 60, no. 4, pp. 613–621, 2002. View at: Publisher Site | Google Scholar
  9. W.-J. Li, R. Tuli, X. Huang, P. Laquerriere, and R. S. Tuan, “Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold,” Biomaterials, vol. 26, no. 25, pp. 5158–5166, 2005. View at: Publisher Site | Google Scholar
  10. Y. Ji, K. Ghosh, X. Z. Shu et al., “Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds,” Biomaterials, vol. 27, no. 20, pp. 3782–3792, 2006. View at: Publisher Site | Google Scholar
  11. D. H. Reneker and I. Chun, “Nanometre diameter fibres of polymer, produced by electrospinning,” Nanotechnology, vol. 7, no. 3, pp. 216–223, 1996. View at: Publisher Site | Google Scholar
  12. M. Li, M. J. Mondrinos, M. R. Gandhi, F. K. Ko, A. S. Weiss, and P. I. Lelkes, “Electrospun protein fibers as matrices for tissue engineering,” Biomaterials, vol. 26, no. 30, pp. 5999–6008, 2005. View at: Publisher Site | Google Scholar
  13. V. J. Chen and P. X. Ma, “The effect of surface area on the degradation rate of nano-fibrous poly(L-lactic acid) foams,” Biomaterials, vol. 27, no. 20, pp. 3708–3715, 2006. View at: Publisher Site | Google Scholar
  14. X. Chen and H. J. Schluesener, “Nanosilver: a nanoproduct in medical application,” Toxicology Letters, vol. 176, no. 1, pp. 1–12, 2008. View at: Publisher Site | Google Scholar
  15. V. Alt, T. Bechert, P. Steinrücke et al., “An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement,” Biomaterials, vol. 25, no. 18, pp. 4383–4391, 2004. View at: Publisher Site | Google Scholar
  16. B. Shan, Y.-Z. Cai, J. D. Brooks, and H. Corke, “Antibacterial properties of Polygonum cuspidatum roots and their major bioactive constituents,” Food Chemistry, vol. 109, no. 3, pp. 530–537, 2008. View at: Publisher Site | Google Scholar
  17. Y. Li, P. Leung, L. Yao, Q. W. Song, and E. Newton, “Antimicrobial effect of surgical masks coated with nanoparticles,” Journal of Hospital Infection, vol. 62, no. 1, pp. 58–63, 2006. View at: Publisher Site | Google Scholar
  18. T. A. Gaonkar, L. A. Sampath, and S. M. Modak, “Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model,” Infection Control and Hospital Epidemiology, vol. 24, no. 7, pp. 506–513, 2003. View at: Publisher Site | Google Scholar
  19. B. Walder, D. Pittet, and M. R. Tramèr, “Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis,” Infection Control & Hospital Epidemiology, vol. 23, no. 12, pp. 748–756, 2002. View at: Publisher Site | Google Scholar
  20. N. S. Morris and D. J. Stickler, “Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine,” Journal of Hospital Infection, vol. 39, no. 3, pp. 227–234, 1998. View at: Publisher Site | Google Scholar
  21. B. Galeano, E. Korff, and W. L. Nicholson, “Inactivation of vegetative cells, but not spores, of Bacillus anthracis, B. cereus, and B. subtilis on stainless steel surfaces coated with an antimicrobial silver- and zinc-containing zeolite formulation,” Applied and Environmental Microbiology, vol. 69, no. 7, pp. 4329–4331, 2003. View at: Publisher Site | Google Scholar
  22. V. Thomas, M. M. Yallapu, B. Sreedhar, and S. K. Bajpai, “A versatile strategy to fabricate hydrogel-silver nanocomposites and investigation of their antimicrobial activity,” Journal of Colloid and Interface Science, vol. 315, no. 1, pp. 389–395, 2007. View at: Publisher Site | Google Scholar
  23. K. K. Lai and S. A. Fontecchio, “Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients,” American Journal of Infection Control, vol. 30, no. 4, pp. 221–225, 2002. View at: Publisher Site | Google Scholar
  24. J. H. Crabtree, R. J. Burchette, R. A. Siddiqi, I. T. Huen, L. L. Hadnott, and A. Fishman, “The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections,” Peritoneal Dialysis International, vol. 23, no. 4, pp. 368–374, 2003. View at: Google Scholar
  25. D. K. Riley, D. C. Classen, L. E. Stevens, and J. P. Burke, “A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection,” The American Journal of Medicine, vol. 98, no. 4, pp. 349–356, 1995. View at: Publisher Site | Google Scholar
  26. F. Furno, K. S. Morley, B. Wong et al., “Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?” Journal of Antimicrobial Chemotherapy, vol. 54, no. 6, pp. 1019–1024, 2004. View at: Publisher Site | Google Scholar
  27. M. Wilson, R. McNab, and B. Henderson, Bacterial Disease Mechanisms: An Introduction to Cellular Microbiology, Cambridge University Press, Cambridge, UK, 2002.
  28. S. Y. Yeo, H. J. Lee, and S. H. Jeong, “Preparation of nanocomposite fibers for permanent antibacterial effect,” Journal of Materials Science, vol. 38, no. 10, pp. 2143–2147, 2003. View at: Publisher Site | Google Scholar
  29. J. Li, Y. Li, L. Li, A. F. T. Mak, F. Ko, and L. Qin, “Fabrication of poly(L-latic acid) scaffolds with wool keratin for osteoblast cultivation,” Advanced Materials Research, vol. 47–50, pp. 845–848, 2008. View at: Publisher Site | Google Scholar
  30. M. Rai, A. Yadav, and A. Gade, “Silver nanoparticles as a new generation of antimicrobials,” Biotechnology Advances, vol. 27, no. 1, pp. 76–83, 2009. View at: Publisher Site | Google Scholar

Copyright © 2009 Lin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.